TRANSFUSION-ASSOCIATED DYSPNOEA

This adverse event was reported 0 times

TRANSFUSION-ASSOCIATED DYSPNOEA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FIBRINOGEN HUMAN 2 0.0086
1 IMMUNE GLOBULIN INFUSION (HUMAN) 17 0.0020
2 DIBASIC POTASSIUM PHOSPHATE 1 0.0018
3 IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 7 0.0011
4 HUMAN IMMUNOGLOBULIN G 16 0.0008
5 ALBUMIN HUMAN 3 0.0006
6 ALBUMIN (HUMAN) 3 0.0005
7 DIMENHYDRINATE 3 0.0003
8 DIPYRIDAMOLE 1 0.0003
9 ERTAPENEM SODIUM 1 0.0001
See all drugs enriched for association with TRANSFUSION-ASSOCIATED DYSPNOEA

TRANSFUSION-ASSOCIATED DYSPNOEA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Human Immunoglobulin G [EPC] 6 0.0003
1 Antimalarial [EPC] 1 0.0001
2 Antiprotozoal [EPC] 1 0.0001
3 Sulfone [EPC] 1 0.0001
4 Microtubule Inhibitor [EPC] 11 0.0001
5 Histamine-2 Receptor Antagonist [EPC] 4 0.0000
6 Platinum-based Drug [EPC] 8 0.0000
7 Rifamycin Antibacterial [EPC] 1 0.0000
8 Protease Inhibitor [EPC] 1 0.0000
9 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
See all drug classes enriched for association with TRANSFUSION-ASSOCIATED DYSPNOEA